Swarthmore Group’s CVS Health CVS Stock Holding History

Swarthmore Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$258K	Sell	2,788 -36,287	-93%	-$3.54M	0.1%	36
2022 Q1	$3.96M	Buy	+39,075	New	+$4.1M	1.01%	41
2016 Q4	–	Sell	-6,150	Closed	-$547K	–	55
2016 Q3	$547K	Hold	6,150	–	–	0.1%	39
2016 Q2	$589K	Hold	6,150	–	–	0.1%	46
2016 Q1	$638K	Hold	6,150	–	–	0.1%	41
2015 Q4	$601K	Buy	6,150 +500	+9%	+$49K	0.06%	43
2015 Q3	$545K	Hold	5,650	–	–	0.06%	39
2015 Q2	$593K	Hold	5,650	–	–	0.06%	35
2015 Q1	$583K	Hold	5,650	–	–	0.05%	36
2014 Q4	$544K	Hold	5,650	–	–	0.05%	39
2014 Q3	$450K	Hold	5,650	–	–	0.04%	43
2014 Q2	$426K	Hold	5,650	–	–	0.04%	44
2014 Q1	$423K	Hold	5,650	–	–	0.05%	38
2013 Q4	$404K	Sell	5,650 -9,475	-63%	-$609K	0.05%	38
2013 Q3	$858K	Sell	15,125 -950	-6%	-$56.6K	0.11%	36
2013 Q2	$919K	Buy	+16,075	New	+$931K	0.12%	34

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Swarthmore Group's CVS Position: Q2 2022 in Review

Swarthmore Group reduced its CVS Health (CVS) stake by 93% in Q2 2022, selling an estimated $3.54M and leaving 2,788 shares worth $258K. The position accounts for 0.1% of the portfolio, ranked #36.

Swarthmore Group first reported a position in CVS in Q2 2013 and has held it in 16 quarters since. The position peaked at $3.96M in Q1 2022. 2,308 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

Swarthmore Group held 2,788 shares of CVS Health worth $258K as of Q2 2022.
Swarthmore Group sold 36,287 CVS Health shares in Q2 2022, an estimated $3.54M.
CVS Health made up 0.1% of Swarthmore Group's portfolio in Q2 2022, its #36 holding.
Swarthmore Group first reported a position in CVS Health in Q2 2013 and has held it in 16 quarters since.
Swarthmore Group's CVS Health position peaked at $3.96M in Q1 2022.
2,308 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on Swarthmore Group's 13F filing for Q2 2022, filed 20 Jul 2022.